Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Translational Development Acquisition (TDAC) Non Operating Income (2024 - 2026)

Translational Development Acquisition's Non Operating Income history spans 3 years, with the latest figure at $1.6 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 11.83% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.1 million, a 262.53% increase, with the full-year FY2025 number at $7.3 million, up 5729.44% from a year prior.
  • Non Operating Income came in at $1.6 million for Q1 2026, down from $1.8 million in the prior quarter.
  • The five-year high for Non Operating Income was $1.9 million in Q3 2025, with the low at $125346.0 in Q4 2024.
  • Historically, Non Operating Income has averaged $1.5 million across 3 years, with a median of $1.8 million in 2025.
  • Biggest five-year swings in Non Operating Income: surged 1302.7% in 2025 and later decreased 11.83% in 2026.
  • Year by year, Non Operating Income stood at $125346.0 in 2024, then skyrocketed by 1302.7% to $1.8 million in 2025, then fell by 8.21% to $1.6 million in 2026.
  • Business Quant data shows Non Operating Income for TDAC at $1.6 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.